Smartleaf Asset Management »

Allogene Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $38k 29k 1.31
2025-03-31 $3.1k 2.0k 1.55

More positions owned by Smartleaf Asset Management

Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Smartleaf Asset Management

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Millennium Management
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation

View all funds holding Allogene Therapeutics